From the Journals
Clinical Guidelines

VA DOD Updates Asthma Framework

Share

The 2025 clinical practice guideline by the US Department of Veterans Affairs and Department of Defense for asthma management emphasizes anti-inflammatory therapy through inhaled corticosteroids (ICS) as the primary strategy. Based on randomized trials involving approximately 22,000 patients, single-device maintenance and reliever therapy (SMART) significantly reduced severe exacerbations by about one-third. The guideline, aimed at primary care providers, recommends ICS for all patients, excluding short-acting beta-agonists (SABAs) for symptom relief, and focuses on managing co-morbid conditions to enhance asthma control.

Original Source(s)

Related Content